Travere Therapeutics, Inc. (TVTX)
35.86
+1.10
(+3.16%)
USD |
NASDAQ |
Dec 16, 16:00
35.86
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Research and Development Expense (Annual): 217.50M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Iovance Biotherapeutics, Inc. | 282.34M |
| Xenetic Biosciences, Inc. | 2.584M |
| KalVista Pharmaceuticals, Inc. | 76.72M |
| BeyondSpring, Inc. | 2.644M |
| Solid Biosciences, Inc. | 96.43M |